Ology Bioservices, Inc.
https://www.ologybio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ology Bioservices, Inc.
Finance Watch: Resilience Raises $625m, Bringing New Cash To $1.2bn
The biomanufacturing firm National Resilience has raised more than $2bn in venture capital and millions more in fees from government and industry contracts since 2020. Also, Code Biotherapeutics raised $75m in series A cash, Concert grossed $66.4m and Amarin is cutting US jobs.
Execs On The Move, July 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Pfizer To Take Zinplava Rival Into Phase III For C Diff
Pfizer will start a Phase III trial for its Clostridium difficile vaccine by the middle of the year, taking aim at the chinks in the armour of Merck & Co’s recently approved Zinplava, but it still trails its rival from Sanofi.
Execs On The Move, January 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Company Information
- Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Distributors
- Pharmaceuticals
- Services
-
Services
- Consulting Services
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Controlled Release
- Macromolecule
- Nasal
- Pulmonary
- Topical Delivery
-
Medical Devices
- Biomaterials
-
Biotechnology
- Large Molecule
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
- Other Names / Subsidiaries
-
- Vion Pharmaceuticals
- Nanotherapeutics, Inc
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice